10-Q: Colgate-Palmolive Q2 2026 Earnings: Sales Rise, Profit Dips Amid Restructuring

Colgate-Palmolive reported a 4.9% increase in net sales for Q2 2026, driven by volume and pricing, but net income attributable to the company decreased due to significant restructuring charges.

Summary

• Colgate-Palmolive reported net sales of $5,361 million for the second quarter of 2026, a 4.9% increase compared to the same period in 2025. This growth was driven by a 0.9% volume increase, 1.6% net selling price increases, and a 2.4% positive foreign exchange impact.
• Organic sales, excluding foreign exchange and acquisitions, increased by 2.4% in the second quarter.
• Net income attributable to Colgate-Palmolive Company decreased to $693 million from $743 million in the prior year's quarter.
• Diluted earnings per share (EPS) decreased to $0.86 from $0.91 in the prior year's quarter.
• The company incurred significant charges related to its Strategic Growth and Productivity Program, impacting profitability.
• The Oral, Personal and Home Care segment saw a 5.4% increase in net sales, while the Hill's Pet Nutrition segment reported a 3.4% increase.
• The company's global toothpaste market share was 41.3% year-to-date, up 0.2 share points, and manual toothbrush market share was 32.7%, up 0.6 share points.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral sentiment; while sales are growing, the decline in net income and EPS due to restructuring costs balances the positive top-line performance.

Positives

• Net sales increased by 4.9% to $5,361 million in Q2 2026, driven by volume growth (0.9%) and net selling price increases (1.6%).
• Organic sales grew by 2.4% in the second quarter, indicating underlying business strength.
• Global toothpaste market share increased to 41.3% year-to-date.
• Global manual toothbrush market share increased to 32.7% year-to-date.
• The Oral, Personal and Home Care segment's organic sales increased by 2.4%.
• The Hill's Pet Nutrition segment's organic sales increased by 2.1%.
• Gross profit margin improved to 61.5% in Q2 2026 from 60.1% in Q2 2025, driven by cost savings and higher pricing.
• Operating profit margin, excluding restructuring charges, increased by 10 bps to 21.4%.

Negatives

• Net income attributable to Colgate-Palmolive Company decreased by 6.7% to $693 million in Q2 2026.
• Diluted earnings per share decreased to $0.86 in Q2 2026 from $0.91 in Q2 2025.
• The Hill's Pet Nutrition segment experienced a volume decline of 1.2%.
• Selling, general and administrative expenses increased by 9% to $2,130 million, partly due to increased advertising investment.
• Operating profit decreased by 6% to $1,016 million in Q2 2026.
• The company incurred $129 million in pre-tax charges related to the Strategic Growth and Productivity Program in Q2 2026.

Risks

• Global macroeconomic, geopolitical, and market conditions are expected to remain challenging, impacting supply chains, material costs, and consumer sentiment.
• The conflict in the Middle East and developments in trade relations, including tariffs, could negatively impact supply chains, material availability, and consumer spending.
• Volatile foreign currency fluctuations are expected, particularly in hyper-inflationary economies like Argentina, Nigeria, and Trkiye.
• Higher raw and packaging material costs, including the impact of transactional foreign exchange, are expected to persist.
• Vigorous worldwide competition, including from local and private label competitors, and the emergence of new competitors through eCommerce and social commerce.
• The company faces challenges in managing disruptions in its global supply chain and the availability and cost of raw materials and logistics.
• The company is subject to ongoing federal, state, and international income tax audits.
• The company is involved in various legal proceedings, including tax and civil proceedings in Brazil and talcum powder product liability cases.

Future Outlook

The company anticipates challenging global macroeconomic, geopolitical, and market conditions, including continued inflationary pressures and market volatility. Consumers may forgo certain products or switch to lower-priced options. Demand and sales volumes may decline or shift to lower-margin products. Volatile foreign currency fluctuations are expected, especially in hyper-inflationary economies. Higher raw and packaging material costs are anticipated. The company expects softness across its categories to continue through the second half of 2026. Competition is expected to remain vigorous, with increasing influence from eCommerce and AI.

Management Comments

• Colgate-Palmolive is a caring, innovative growth company united behind our purpose to reimagine a healthier future for all people, their pets and our planet.
• We are focused on driving organic sales growth; delivering consistent, compounded earnings per share growth; achieving operational efficiencies; and driving growth in free cash flow along with the efficient use of our balance sheet.
• We believe strong free cash flow performance is key to enabling us to invest for future growth and superior total shareholder return.
• Our 2030 business strategy and the Strategic Growth and Productivity Program will help ensure that we have the right capabilities and support to achieve our goals in the near term and to deliver consistent, compounded earnings per share growth over the long term.

Industry Context

StockSavvy.ai notes that Colgate-Palmolive's performance reflects broader trends in the consumer staples sector, including persistent inflation impacting raw material costs and consumer spending, alongside increased competition driven by digital channels and AI integration. The company's focus on organic growth and productivity programs aligns with industry efforts to navigate these complex market dynamics.

Comparison to Industry Standards

• Colgate-Palmolive's toothpaste market share of 41.3% and manual toothbrush market share of 32.7% are strong positions within their respective global categories, often exceeding industry averages for dominant players in mature markets.
• The company's gross profit margin of 61.5% is robust and generally higher than many competitors in the broader consumer staples sector, reflecting strong brand equity and pricing power.
• The reported organic sales growth of 2.4% is in line with expectations for a mature consumer goods company operating in a challenging global economic environment, where significant growth rates are difficult to achieve consistently.

Legal Proceedings

• Ongoing tax and civil proceedings in Brazil related to the 1995 acquisition of Kolynos oral care business, with assessments totaling approximately $105 million.
• Talcum powder product liability cases: 525 individual cases pending as of June 30, 2026, alleging asbestos contamination and health issues.
• ERISA litigation matter settled for $332 million, with attorneys' fees of $99 million paid by the company.

Stakeholder Impact

• Shareholders: Potential for continued EPS growth long-term, but short-term impact from restructuring charges and potential for share price volatility.
• Employees: Restructuring may lead to workforce adjustments, though specific details are not provided.
• Suppliers: The supplier finance program allows suppliers to receive early payment at a discount, managed through accounts payable.
• Creditors: The company's debt levels and ability to service debt are key considerations.

Next Steps

• Continue to implement the Strategic Growth and Productivity Program, which is estimated to incur cumulative pre-tax charges between $350 and $550 million by December 31, 2028.
• Focus on driving organic sales growth and delivering consistent earnings per share growth.
• Continue to invest in brand support and market products at multiple price points.
• Monitor and mitigate the impact of global macroeconomic, geopolitical, and market challenges.
• Evaluate the potential impact of the Pillar II Side-by-Side Package on future tax liability and compliance.

Key Dates

Recommendation

The company demonstrates consistent sales growth and market share gains, but the significant restructuring charges are impacting profitability and EPS in the short term. The long-term strategy appears sound, but near-term headwinds and ongoing legal matters warrant a cautious 'hold' stance until the benefits of the restructuring become clearer and the impact of global economic uncertainties diminishes.

Keywords

Colgate-Palmolive, Oral Care, Pet Nutrition, Consumer Staples, Global Sales, Restructuring, Earnings Report, Hills Pet Nutrition